Literature DB >> 2128987

Microlamellar structures in lobular glomerulonephritis associated with monoclonal IgG lambda paraproteinemia. A case report and review of the literature.

K Joh1, S Aizawa, T Takahashi, M Hatakeyama, S Muto, Y Asano, H Shimizu, R Suzuki.   

Abstract

We report a 49-year-old woman who developed lobular glomerulonephritis with prevalent deposition of material positive for IgG, C1q and lambda light chain, but which was not stained by Congo red. Glomeruli revealed massive electron-dense deposits with a microlamellar structure in the mesangial matrix and peripheral capillary loops. Clinically, the patient had nephrotic syndrome, microhematuria and hypertension. No Bence-Jones protein or cryoglobulin was found in the urine or serum. Anti-DNA antibody was positive, but systemic lupus erythematosus (SLE) was ruled out by repeated serological examinations. Immunoelectrophoresis of blood and urine revealed increased IgG-lambda paraprotein, but no free light chains were found. We reviewed 54 cases reported in the literature, which showed organized crystalline structures on ultrastructural examination, but were unassociated with amyloidosis, SLE, cryoglobulinemia or multiple myeloma. The present patient is the first reported to have exhibited a combination of glomerulonephritis with organized deposits, monoclonal IgG lambda paraproteinemia, and the presence of anti-DNA antibody.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2128987     DOI: 10.1111/j.1440-1827.1990.tb03338.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  2 in total

1.  Proliferative glomerulonephritis with unusual microlamellar organized deposits related to monoclonal immunoglobulin G3 (IgG3) kappa.

Authors:  Akiko Mii; Akira Shimizu; Daisuke Takada; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2018-07-09

2.  A case of membranoproliferative glomerulonephritis associated with curved fibril deposition.

Authors:  Ikuyo Narita; Michiko Shimada; Takeshi Fujita; Reiichi Murakami; Masayuki Nakamura; Norio Nakamura; Hideaki Yamabe; Ken Okumura
Journal:  BMC Nephrol       Date:  2015-09-15       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.